Core Viewpoint - Langzi Co., Ltd. forecasts a significant increase in net profit for 2025, indicating strong financial performance and growth potential [1] Financial Performance - The company expects net profit attributable to shareholders to be between 900 million and 1.05 billion yuan, representing an increase of 245.25% to 302.8% compared to the previous year [1] - The net profit after deducting non-recurring gains and losses is projected to be between 220 million and 290 million yuan, showing a growth of 1.09% to 33.25% year-on-year [1]

Group 1 - The company, Langzi Co., Ltd. (002612.SZ), forecasts a net profit attributable to shareholders of 900 million to 1.05 billion yuan for the year 2025, representing a year-on-year increase of 245.25% to 302.80% [1] - The net profit after deducting non-recurring gains and losses is expected to be between 220 million to 290 million yuan, with a year-on-year growth of 1.09% to 33.25% [1]

Group 1 - The company, Langzi Co., Ltd. (002612.SZ), has disclosed its annual performance forecast for 2025, expecting a net profit attributable to shareholders of between 900 million to 1.05 billion yuan, representing a year-on-year growth of 245.25% to 302.80% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 220 million to 290 million yuan, with a year-on-year growth of 1.09% to 33.25% [1]

Core Viewpoint - Langzi Co., Ltd. (002612.SZ) announced a performance forecast for the year 2025, expecting a net profit attributable to shareholders of between 900 million and 1.05 billion yuan, representing a year-on-year growth of 245.25% to 302.80% [1] Financial Performance - The significant increase in net profit is attributed to the disposal of part of the shares in Ruoyuchen and the conversion of remaining equity into trading financial assets, leading to recognition of investment income and fair value changes [1]

每经AI快讯，1月20日，朗姿股份(002612.SZ)公告称，朗姿股份发布2025年度业绩预告，预计归属于上 市公司股东的净利润为9.00亿元~10.50亿元，比上年同期增长245.25%~302.80%。报告期内，公司处置 若羽臣部分股票并将剩余股权转为交易性金融资产，确认投资收益及公允价值变动损益，导致净利润大 幅上升。 ...

2025年度归属于公司股东的净利润较上年同期同比大幅上升的主要原因是：本期处置广州若羽臣科技股 份有限公司（简称"若羽臣"）部分股票以及将若羽臣剩余股权从长期股权投资转为交易性金融资产确认 投资收益和后续公允价值变动损益所致，其影响净利润金额约为72,500万元。根据《公开发行证券的公 司信息披露解释性公告第1号——非经常性损益》的相关规定，上述投资收益以及公允价值变动损益计 入非经常性损益项目。 格隆汇1月20日丨朗姿股份(002612.SZ)公布，预计2025年归属于上市公司股东的净利润90,000万元– 105,000万元，比上年同期上升245.25%-302.80%，扣除非经常性损益后的净利润22,000万元–29,000万 元，比上年同期上升1.09%-33.25%。 ...

证券代码：002612 证券简称：朗姿股份 公告编号：2026-006 一、本期业绩预计情况 朗姿股份有限公司（以下简称"公司"）是否需追溯调整或重述以前年度会 计数据：是 追溯调整原因：同一控制下企业合并 2025 年 9 月，公司下属全资子公司北京朗姿医疗管理有限公司以现金方式 收购重庆米兰柏羽时光整形美容医院有限公司（以下简称"重庆时光"）67.50% 股权。本次收购属于同一控制下企业合并，按照《企业会计准则》相关规定，需 对 2024 年 12 月 31 日的合并资产负债表、2024 年 1-12 月的合并利润表及合并 现金流量表相关财务数据进行追溯调整，即公司将重庆时光 2024 年 1-12 月和 2025 年 1-9 月的经营成果及现金流量纳入合并财务报表。 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日 （二）业绩预告情况 预计净利润为正值且属于下列情形：同比上升 朗姿股份有限公司 2025年年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特此公告。 朗姿股份有限公司董事会 以区间进行业绩预告 ...

Core Viewpoint - The company, Langzi Co., Ltd., expects a significant increase in net profit for the fiscal year 2025, projecting a range of 900 million to 1.05 billion yuan, representing a year-on-year growth of 245.25% to 302.80% [1] Financial Performance - The anticipated increase in net profit is primarily attributed to the disposal of a portion of shares in Guangzhou Ruoyuchen Technology Co., Ltd. (referred to as "Ruoyuchen") and the reclassification of remaining equity in Ruoyuchen from long-term equity investment to trading financial assets, which will recognize investment income and subsequent fair value changes [1] - The impact on net profit from these activities is estimated to be approximately 725 million yuan [1]

Core Viewpoint - The company is accelerating its national layout in the medical beauty business and establishing a long-term incentive mechanism through investments in new or existing medical beauty institutions by its wholly-owned subsidiary, Langzi Medical Management Group [2] Group 1: Business Strategy - Langzi Medical Management Group is collaborating with management and key employees in the medical beauty sector to invest in new medical beauty institutions [2] - The transaction aims to enhance the motivation of key employees and improve the operational performance of the subsidiary, constituting a related party transaction [2] Group 2: Financial Performance - For the first three quarters of 2025, the company achieved total operating revenue of 4.328 billion yuan, representing a year-on-year increase of 0.89% [2] - The net profit attributable to the parent company reached 989 million yuan, showing a significant year-on-year growth of 366.95% [2] Group 3: Risk Management - The company asserts that the arrangement is controllable in terms of risk and will not have a significant adverse impact on its financial and operational status [2] - There are no circumstances that would harm the rights and interests of the listed company and minority shareholders [2] - The company will follow approval and information disclosure procedures for any future related party transactions to ensure fair pricing [2]

Group 1 - The company held its 37th meeting of the fifth board of directors on January 16, 2026, to discuss and approve a proposal regarding joint investment with related parties [2][4] - The proposal aims to accelerate the national layout strategy of the company's medical beauty business and establish a long-term incentive and restraint mechanism for key employees [3][8] - The company has been utilizing employee stock ownership platforms to jointly invest in new medical beauty institutions since July 2017, with the full subsidiary, Langzi Medical Management Group Co., Ltd., acting as the general partner [3][8] Group 2 - The board approved the proposal with a unanimous vote, with one related director abstaining from the vote [4][9] - The independent directors held a special meeting and agreed that the pricing and terms of the related transactions are fair and do not harm the interests of the company or its minority shareholders [29][30] - The expected investment amounts for key personnel involved in the employee stock ownership platforms were detailed, with specific figures provided for each individual [10][12][14][15]